(Press-News.org) CLEVELAND, Ohio (Oct 21, 2025)—Digestive health issues are highly prevalent among perimenopausal and menopausal women, with many reporting the onset or exacerbation of symptoms during this life stage. Despite symptom burden, formal diagnoses and effective treatment remain limited. That’s the conclusion of a new study focused on gut health during the menopause transition. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
The hormone changes experienced during perimenopause and menopause can cause a variety of gastrointestinal symptoms, which are often dismissed as normal aging or attributed to other issues. Digestive complaints like bloating, gas, stomach pain, and constipation are common to menopause, as well as other health problems.
A new study out of the UK aimed to explore just how common such digestive health problems are among perimenopausal and menopausal women. It also sought to understand current management strategies and the impact of symptoms on health-related quality of life.
Of the nearly 600 study participants aged 44 to 73, a striking 94% reported experiencing digestive health symptoms, with bloating (77%), constipation (54%), stomach pain (50%), and acid reflux (49%) being the most common. Despite the high incidence of problems with their guts, only 33% had received a formal diagnosis of irritable bowel syndrome (IBS). The majority (82%) reported either the onset or worsening of symptoms at perimenopause or menopause.
Statistically significant associations were found between menopause groupings and specific symptoms, particularly bloating and stomach pain. While 53% had sought professional support, 58% of them found it inadequate. Most (89%) tried self-management strategies, including dietary changes, stress management, and supplements. Over half experienced daily or weekly symptoms, with 55% reporting a significant or regular impact on their quality of life.
The findings underscore the need for increased clinical awareness, targeted support strategies, and further research into the intersection between digestive health and menopause. Improving healthcare professional education and broadening research efforts could enhance diagnosis, management, and ultimately, quality of life for women navigating menopause.
“Digestive health problems at midlife are often brushed aside, yet our research shows they are both widespread and impactful for women,” says Nigel Denby, lead author and a registered dietitian based in London. “By raising awareness of this hidden burden, we hope to encourage healthcare professionals to ask the right questions, validate women’s experiences, and work towards better support and treatment options during menopause.”
More details from the study will be presented at the 2025 Annual Meeting of The Menopause Society as part of the poster presentation entitled “Menopause and the Gut: Uncovering a Hidden Health Burden.”
“These results are noteworthy because they demonstrate how many women are experiencing frequent gastrointestinal symptoms and either not seeking care or receiving what they perceive to be inadequate care,” says Dr. Stephanie Faubion, medical director for The Menopause Society. “Symptoms like hot flashes, night sweats, and mood changes are more widely recognized as symptoms of menopause, so it can be easy to overlook or underestimate the significance of digestive issues that may be happening at the same time.”
Both Nigel Denby and Dr. Faubion are available for interviews prior to the Annual Meeting.
For more information about menopause and healthy aging, visit menopause.org.
The Menopause Society is dedicated to empowering healthcare professionals and providing them with the tools and resources to improve the health of women during the menopause transition and beyond. As the leading authority on menopause since 1989, the nonprofit, multidisciplinary organization serves as the independent, evidence-based resource for healthcare professionals, researchers, the media, and the public and leads the conversation about improving women’s health and healthcare experiences. To learn more, visit menopause.org.
END
Digestive issues more common during perimenopause and menopause
New study showcases high prevalence of symptoms like bloating, constipation, stomach pain, and acid reflex at midlife
2025-10-21
ELSE PRESS RELEASES FROM THIS DATE:
Oral or transdermal hormone therapy? The mental health risks are not the same
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Hormone therapy–oral and transdermal–remains the most effective treatment for such bothersome menopause symptoms as hot flashes and is generally considered safe for most patients. A new study shows that risk profiles are different based on how the hormones are administered. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
When it comes to hormone therapy, there is not a consistently preferred route of administration. ...
When women initiate estrogen therapy matters
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone therapy has proven valuable in managing bothersome menopause symptoms. A new study suggests that when a woman starts taking hormones makes a major difference in longer term health outcomes. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
A large percentage of women will experience some type of menopause symptoms, with the most common symptom ...
Risk of eye disease increases during menopause transition
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Many symptoms, such as hot flashes and vaginal dryness, are commonly associated with the menopause transition. One of the lesser-known symptoms that worsens in midlife is dry eyes. A new study suggests that postmenopausal women exhibit a higher prevalence of dry eye disease than perimenopausal women. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
Dry eye disease is a relatively common disease characterized by eyes not providing enough tears or ...
Life in the fast (and slow) lanes for salmon
2025-10-21
Kyoto, Japan -- Life-history variation is fundamental to the long-term persistence of populations and species because it ensures their ability to adapt to changing environments. Many important studies have focused on life-history variation between habitats, but the variation maintained within a habitat has often been overlooked.
Unravelling this puzzle at the landscape level is critical for understanding the spatial scales at which adaption and population persistence operate in nature. This motivated a team of researchers at Kyoto University to investigate life-history variation in masu salmon.
"We wanted to understand how the variation in life-history is partitioned within and ...
Early natural menopause linked with higher risk of metabolic syndrome
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—The prevalence of metabolic syndrome, a dangerous and potentially deadly condition, increases with menopause. That’s the result of decreasing estrogen that protects against these metabolic conditions. A new study not only identified the prevalence of metabolic syndrome but also sought to determine its association with the age of natural menopause. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando, October 21-25.
Metabolic syndrome is a serious condition because it is a cluster of risk factors, including obesity, high blood pressure, ...
Earlier menopause and reduced cardiac function can take a toll on brain health
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Women face a higher risk of developing both cardiovascular disease and Alzheimer’s disease than men. Cardiovascular disease is linked to an increased likelihood of Alzheimer’s disease, especially among women. A new study investigated whether earlier age at menopause influences the association between cardiac function and brain health. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
Reduced cardiac function can affect brain health by limiting the essential supply of oxygen and ...
Feeling anxious during menopause? Hormone therapy may or may not help
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Anxiety is a common and significant symptom of menopause and perimenopause, largely due to hormone fluctuations. Numerous studies have focused on the potential benefits of hormone therapy in reducing anxiety. A new systematic review indicates the treatment does not consistently impact anxiety symptoms in midlife women. Results of the review will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando, October 21-25.
Anxiety can manifest in a number of ways, including nervousness, ...
Likelihood of being prescribed hormone therapy may depend on the type of provider seen
2025-10-21
CLEVELAND, Ohio (Oct 21, 2025)—Not all healthcare professionals receive the same type of formal education. That may help explain the results of a new study which suggests that provider type and specialty greatly affect whether a woman receives prescription medication treatment for menopause-related care and, if so, what kind of treatment she receives. Results of the study will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
Menopause represents a time of significant physiological and psychosocial transition with symptoms that affect up to 80% of women. Hormone therapy ...
The role of genetics in modifying the link between earlier menopause and memory decline
2025-10-21
CLEVELAND, Ohio (Oct 22, 2025)—Women are significantly more likely than men to develop Alzheimer’s disease. Earlier age at menopause is associated with a greater risk for late-life cognitive decline and Alzheimer’s disease. A new study suggests that this risk is even higher in women who carry the APOE e4 gene variant or who have systemic inflammation. Study results will be presented at the 2025 Annual Meeting of The Menopause Society in Orlando October 21-25.
There are a number of reasons why women are more likely than men to develop Alzheimer’s ...
Who watches the AI watchman?
2025-10-21
As artificial intelligence (AI) takes on increasingly critical roles — from managing power grids to piloting autonomous vehicles — making sure these systems are safe has never been more important. But how can we be certain that the AI controlling them can be trusted?
A research team at the University of Waterloo is addressing this question using tools from applied mathematics and machine learning to rigorously check and verify the safety of AI-driven systems.
“Any time you’re dealing with a dynamic system — something ...
LAST 30 PRESS RELEASES:
Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance
Using social media may impair children’s attention
Science briefing: An update on GLP-1 drugs for obesity
Lower doses of immunotherapy for skin cancer give better results
Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility
ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment
A sound defense: Noisy pupae puff away potential predators
Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
New findings support a chemo-free approach for treating Ph+ ALL
Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
University of Cincinnati experts present research at annual hematology event
ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors
Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
Continuous and fixed-duration treatments result in similar outcomes for CLL
Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia
Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease
Roughly one-third of families with children being treated for leukemia struggle to pay living expenses
Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection
Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients
Emergency departments fall short on delivering timely treatment for sickle cell pain
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease
Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia
Early results suggest exa-cel gene therapy works well in children
NTIDE: Disability employment holds steady after data hiatus
Social lives of viruses affect antiviral resistance
[Press-News.org] Digestive issues more common during perimenopause and menopauseNew study showcases high prevalence of symptoms like bloating, constipation, stomach pain, and acid reflex at midlife